Brainstorm Cell Therapeutics | BCLI - Current Liabilities


Brainstorm Cell Therapeutics reported $9.02M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 4.38M 849.82K Jun/2023
Biogen USD 3.35B 59.4M Dec/2025
Brainstorm Cell Therapeutics USD 9.02M 495K Sep/2025
Cipla INR 62.97B 8.13B Sep/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 20.28M 300K Sep/2025
CSL USD 4.61B 207M Dec/2025
Cytokinetics USD 202.45M 60.31M Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
Grifols EUR 2.53B 182.67M Sep/2025
Halozyme Therapeutics USD 177.09M 660.14M Dec/2025
Mesoblast USD 128.07M 25.44M Dec/2025